Literature DB >> 19949161

Alexithymia is associated with increased cardiovascular mortality in middle-aged Finnish men.

Tommi Tolmunen1, Soili M Lehto, Maria Heliste, Sudhir Kurl, Jussi Kauhanen.   

Abstract

OBJECTIVE: To explore the associations between alexithymia and increased somatic morbidity. The mechanisms underlying these associations, however, are still unclear. Furthermore, data on the association between alexithymia and mortality are scarce.
METHODS: A total of 2321 Finnish men, aged 46 to 61 years, were followed up for an average of 20 years. Mortality rates were obtained from the national register. The associations between baseline alexithymia and cardiovascular disease (CVD), all-cause, injury, and cancer deaths were examined with adjustments for age and several behavioral (smoking, alcohol consumption, physical activity), physiological (low- and high-density lipoprotein cholesterol, body mass index, systolic blood pressure, history of CVD), and psychosocial (marital status, education, depression) factors.
RESULTS: After all adjustments, the risk of CVD death was increased by 1.2% for each 1-point increase in Toronto Alexithymia Scale-26 scores.
CONCLUSIONS: Alexithymia is associated with increased cardiovascular mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19949161     DOI: 10.1097/PSY.0b013e3181c65d00

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  18 in total

Review 1.  Personality traits and emotional patterns in irritable bowel syndrome.

Authors:  Maria Rosaria A Muscatello; Antonio Bruno; Carmela Mento; Gianluca Pandolfo; Rocco A Zoccali
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

2.  Paradoxical somatic information processing for interoception and anxiety in alexithymia.

Authors:  Yuri Terasawa; Kentaro Oba; Yuki Motomura; Ruri Katsunuma; Hiroki Murakami; Yoshiya Moriguchi
Journal:  Eur J Neurosci       Date:  2021-11-25       Impact factor: 3.698

3.  Four decades of research on alexithymia: moving toward clinical applications.

Authors:  Dalya Samur; Mattie Tops; Caroline Schlinkert; Markus Quirin; Pim Cuijpers; Sander L Koole
Journal:  Front Psychol       Date:  2013-11-19

4.  Gender, alexithymia and physical inactivity associated with abdominal obesity in type 1 diabetes mellitus: a cross sectional study at a secondary care hospital diabetes clinic.

Authors:  Eva O Melin; Ralph Svensson; Maria Thunander; Magnus Hillman; Hans O Thulesius; Mona Landin-Olsson
Journal:  BMC Obes       Date:  2017-06-02

5.  Alexithymia in Gastroenterology and Hepatology: A Systematic Review.

Authors:  Danilo Carrozzino; Piero Porcelli
Journal:  Front Psychol       Date:  2018-04-06

6.  Personality is of central concern to understand health: towards a theoretical model for health psychology.

Authors:  Eamonn Ferguson
Journal:  Health Psychol Rev       Date:  2013-05-28

7.  Alexithymia as a prognostic risk factor for health problems: a brief review of epidemiological studies.

Authors:  Masayo Kojima
Journal:  Biopsychosoc Med       Date:  2012-12-17

8.  Psychological factors, including alexithymia, in the prediction of cardiovascular risk in HIV infected patients: results of a cohort study.

Authors:  Giustino Parruti; Francesco Vadini; Federica Sozio; Elena Mazzott; Tamara Ursini; Ennio Polill; Paola Di Stefano; Monica Tontodonati; Maria C Verrocchio; Mario Fulcheri; Giulio Calella; Francesca Santilli; Lamberto Manzoli
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

9.  The alexithymic brain: the neural pathways linking alexithymia to physical disorders.

Authors:  Michiko Kano; Shin Fukudo
Journal:  Biopsychosoc Med       Date:  2013-01-09

10.  Affect school and script analysis versus basic body awareness therapy in the treatment of psychological symptoms in patients with diabetes and high HbA1c concentrations: two study protocols for two randomized controlled trials.

Authors:  Eva O Melin; Ralph Svensson; Sven-Åke Gustavsson; Agneta Winberg; Ewa Denward-Olah; Mona Landin-Olsson; Hans O Thulesius
Journal:  Trials       Date:  2016-04-27       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.